Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Boehringer and IBM to explore blockchain technology in clinical trials

Boehringer
Boehringer announces positive cardiovascular outcomes for linagliptin. Credit: © Boehringer Ingelheim.